StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 1

Amsterdam University Medical Centers0 个研究点目标入组 6 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•1Age >18 years
•2Implanted ICD
•3World Health Organization (WHO) / Eastern Cooperative Oncology Group (ECOG) performance status grade 0-3 in the
•past 3 months (from fully active to capable of limited self-care, see below for full explanation)
•4 At least 3 episodes of treated VT within the last 3 months
•5 Recurrence of VT after
•-Failed or intolerant to least one class 1 or class 3 anti-arrhythmic drug
•-At least one catheter ablation procedure OR considered to be unsuitable for a catheter ablation procedure (e.g. no
•sufficient vascular access, considered unfit to undergo prolonged general anesthesia, comorbid conditions resulting
•in unacceptable peri-procedural risks)
•6 Able and willing to undergo all necessary evaluations, treatment and follow-up for the study and of follow-up thereafter
•7 Informed consent

•2History of radiation treatment in the thorax or upper abdominal region
•3Interstitial pulmonary disease
•4Renal insufficiency with a glomerular filtration rate <30ml/min
•5Refusal or inability to provide informed consent or to undergo all necessary evaluations, treatment and follow-up for the

发起方

Amsterdam University Medical Centers